Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.

Saved in:
Bibliographic Details
Title: Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.
Authors: Berman DM; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Lee AY; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Lesurf R; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Now with Hospital for Sick Children, Toronto, Ontario, Canada., Patel PG; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.; Now with Hospital for Sick Children, Toronto, Ontario, Canada., Ebrahimizadeh W; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.; Now with IMV Inc, Dartmouth, Nova Scotia, Canada., Bayani J; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Ontario, Canada., Lee LA; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Boufaied N; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Selvarajah S; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.; Now with University Health Network, Toronto, Ontario, Canada., Jamaspishvili T; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Guérard KP; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Dion D; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Kawashima A; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.; Now with Osaka University, Osaka, Japan., Clarke GM; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., How N; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.; Hamilton Health Sciences, Hamilton, Ontario, Canada., Jackson CL; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Scarlata E; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Siddiqui K; Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; Now with Sultan Qaboos University Hospital, Seeb, Oman., Okello JBA; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., Aprikian AG; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Moussa M; Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada., Finelli A; Princess Margaret Cancer Centre. Toronto, Ontario, Canada.; Departments of Surgery and Oncology, University of Toronto, Toronto, Ontario, Canada., Chin J; Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada., Brimo F; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.; Department of Pathology, McGill University, Montreal, Quebec, Canada., Bauman G; Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada., Loblaw A; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Departments of Radiation Oncology and Health Policy Management and Evaluation, University of Toronto, Toronto., Venkateswaran V; Departments of Surgery and Oncology, University of Toronto, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada., Buttyan R; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Departments of Experimental Medicine and Interdisciplinary Oncology, Vancouver, British Columbia, Canada., Chevalier S; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Thomson A; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.; Now with College of Science and Engineering Biology, University of Edinburgh, Edinburgh, United Kingdom., Park PC; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.; Now with Department of Pathology, Shared Health, Winnipeg, Manitoba, Canada., Siemens DR; Queen's University Cancer Research Institute, Kingston, Ontario, Canada.; Departments of Urology, Oncology and Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Lapointe J; Department of Surgery, McGill University and the Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Boutros PC; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.; Now with University of California, Los Angeles, Los Angeles, California, United States., Bartlett JMS; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Ontario, Canada.; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, United Kingdom.
Source: The Journal of urology [J Urol] 2023 Aug; Vol. 210 (2), pp. 257-271. Date of Electronic Publication: 2023 May 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3792
DOI:10.1097/JU.0000000000003507